Periprocedural outcomes of prophylactic protamine administration for reversal of heparin after cryoballoon ablation of atrial fibrillation

Journal of Interventional Cardiac Electrophysiology

Volumn 41, Issue 2, 2014, Pages 129-134

  Conte, Giulio ^a   de Asmundis, Carlo ^a   Baltogiannis, Giannis ^a   Di Giovanni, Giacomo ^a   Ciconte, Giuseppe ^a   Sieira, Juan ^a   Saitoh, Yukio ^a   Wauters, Kristel ^a   Mugnai, Giacomo ^a   Julià, Justo ^a   Irfan, Ghazala ^a   Levinstein, Moises ^a   Cotino Moreno, Hugo Enrique ^a   Chierchia, Gian Battista ^a   Brugada, Pedro ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Ablation; Atrial fibrillation; Cryoballoon; Heparin; Protamine

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEPARIN; PROTAMINE; THROMBIN; WARFARIN; HEPARIN ANTAGONIST;

ABLATION CATHETER; ABSENCE OF SIDE EFFECTS; ADULT; ANTICOAGULANT THERAPY; ARTICLE; BRAIN ISCHEMIA; CATHETER SHEATH; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOABLATION; CRYOBALLOON ABLATION; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; FALSE ANEURYSM; FEMALE; FEMORAL PSEUDOANEURYSM; FLUOROSCOPY; GROIN HEMATOMA; HEART ATRIUM FIBRILLATION; HEART TAMPONADE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MAPPING CATHETER; MIDDLE AGED; NONSURGICAL INVASIVE THERAPY; OUTCOME ASSESSMENT; PROPHYLAXIS; PROSPECTIVE STUDY; SHEATH REMOVAL; VASCULAR DISEASE; AGED; ATRIAL FIBRILLATION; CASE CONTROL STUDY; CATHETER ABLATION; COMPARATIVE STUDY; DEVICES; ELECTROCARDIOGRAPHY; FOLLOW UP; NONPARAMETRIC TEST; PEROPERATIVE CARE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PRIMARY PREVENTION; PROCEDURES; THROMBOSIS; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; CATHETER ABLATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PRIMARY PREVENTION; PROSPECTIVE STUDIES; PROTAMINES; STATISTICS, NONPARAMETRIC; THROMBOSIS; TREATMENT OUTCOME;

EID: 84910121930     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-014-9922-y     Document Type: Article

References (17)

1. Van Belle, Y., Janse, P., Rivero-Ayerza, M. J., Thornton, A. S., Jessurun, E. R., Theuns, D., et al. (2007). Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: feasibility, complications, and short-term outcome. European Heart Journal, 28, 2231–2237.
2. Packer, D. L., Kowal, R. C., Wheelan, K. R., Irwin, J. M., Champagne, J., Guerra, P. G., et al. (2013). Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. Journal of the American College of Cardiology, 61(16), 1713–1723.
3. Andrade, J. G., Khairy, P., Guerra, P. G., Deyell, M. W., Rivard, L., Macle, L., et al. (2011). Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies. Heart Rhythm, 8(9), 1444–1451.
4. Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S. A., et al. (2012). HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Journal of Interventional Cardiac Electrophysiology, 2012, 171–257
5. Pan, M., Suárez de Lezo, J., Medina, A., Romero, M., Hernández, E., Segura, J., et al. (1997). In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation. American Journal of Cardiology, 80(10), 1336–1338.
6. Briguori, C., Di Mario, C., De Gregorio, J., Sheiban, I., Vaghetti, M., & Colombo, A. (1999). Administration of protamine after coronary stent deployment. American Heart Journal, 138(1 Pt 1), 64–68.
7. Kuiper, K. K., & Nordrehaug, J. E. (2000). Early mobilization after protamine reversal of heparin following implantation of phosphorylcholine-coated stents in totally occluded coronary arteries. American Journal of Cardiology, 85(6), 698–702.
8. Patel, A. A., Clyne, C. A., Henyan, N. N., White, C. M., Zembrowski, B. F., Migeed, M., et al. (2007). The use of protamine after radiofrequency catheter ablation: a pilot study. Journal of Interventional Cardiac Electrophysiology, 18(2), 155–158.
9. Chierchia, G. B., Di Giovanni, G., Sieira-Moret, J., de Asmundis, C., Conte, G., Rodriguez-Mañero, M., et al. (2014). Initial experience of three-minute freeze cycles using the second-generation cryoballoon ablation: acute and short-term procedural outcomes. Journal of Interventional Cardiac Electrophysiology, 39(2), 145–151.
10. Zhou, L., Keane, D., Reed, G., & Ruskin, J. (1999). Thromboembolic complications of cardiac radiofrequency catheter ablation: a review of the reported incidence, pathogenesis and current research directions. Journal of Cardiovascular Electrophysiology, 10(4), 611–620.
11. Cobel-Geard, R. J., & Hassouna, H. I. (1983). Interaction of protamine sulfate with thrombin. American Journal of Hematology, 14, 227–233.
12. Chu, A. J., Wang, Z., Raicu, M., Beydoun, S., & Ramos, N. (2001). Protamine inhibits tissue factor-initiated extrinsic coagulation. British Journal of Haematology, 115, 392–399.
13. Nielsen, V. G. (2006). Protamine enhances fibrinolysis by decreasing clot strength: role of tissue factor-initiated thrombin generation. Annals of Thoracic Surgery, 81, 1720–1727.
14. Ni Ainle, F., Preston, R. J. S., Jenkins, P. V., Nel, H. J., Johnson, J. A., Smith, O. P., et al. (2009). Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation. Blood, 114, 1658–1665.
15. Barstad, R. M., Stephens, R. W., Hamers, M. J., & Sakariassen, K. S. (2000). Protamine sulfate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity. Thrombosis & Haemostasis, 83, 334–337.
16. Horrow, J. C. (1985). Protamine: a review of its toxicity. Anesthesia and Analgesia, 64(3), 348–361.
17. Chilukuri, K., Henrikson, C. A., Dalal, D., Scherr, D., MacPherson, E. C., Cheng, A., et al. (2009). Incidence and outcomes of protamine reactions in patients undergoing catheter ablation of atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 25(3), 175–181.